Related Experiment Video
Updated: Aug 1, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Drug Shelf Life and Release Limits Estimation Based on Manufacturing Process Capability.
Alexis Oliva1, Matías Llabrés2
1Departamento de Ingeniería Química y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de La Laguna, 38200 Tenerife, Spain.
This study introduces a new method for determining drug shelf life based on manufacturing process capability and degradation rates. The approach ensures drug quality remains within specifications until expiration, utilizing stability data and analytical validation.
Area of Science:
- Pharmaceutical Sciences
- Drug Stability
- Quality Control
Background:
- Specification limits are set by regulatory agencies, while release limits are internal manufacturer specifications.
- Ensuring drug quality attributes remain within limits until expiration is critical for patient safety.
- Current methods for shelf-life determination can be refined by integrating manufacturing process capacity and degradation kinetics.
Purpose of the Study:
- To propose and validate a novel method for establishing drug shelf life.
- To integrate drug manufacturing process capacity and degradation rate into shelf-life estimation.
- To ensure that drug products meet quality standards throughout their intended shelf life.
Main Methods:
- A modified version of the Allen et al. (1991) method was employed.
- Analytical method validation was performed to determine insulin concentration and estimate specification limits.
- Stability data from six human insulin batches were analyzed, divided into groups for shelf-life estimation and release limit testing.
- The ASTM E2709-12 approach was used to verify future batch compliance.
- The entire procedure was implemented using R-code.
Main Results:
- The study successfully developed and implemented a method for setting shelf life based on process capacity and degradation.
- Specification limits were estimated using analytical method validation data for insulin concentration.
- Stability data analysis allowed for the estimation of shelf life and testing of the lower release limit (LRL).
- The ASTM E2709-12 standard provided a framework for verifying batch release criteria.
Conclusions:
- The proposed method offers a robust approach to determining shelf life by considering manufacturing process capabilities.
- This method enhances the assurance of drug quality and stability until the expiry date.
- The R-code implementation facilitates the practical application of this shelf-life determination strategy.
More Related Videos
11:27A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
Published on: August 9, 2022
05:45Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
Published on: April 7, 2023
Related Concept Videos
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
Noncompartmental Analysis: Mean Transit, Absorption and Dissolution Time
One of the key parameters is the mean transit time (MTT), which refers to the total duration required for drug molecules to transit through the body. MTT is determined by calculating the ratio of the area under the moment curve to the area...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Factors Influencing Drug Absorption: Drug Dissolution